Clinicians Are Treating MOC as an Antitrust Problem, Not a Points Problem

Key Takeaways

• Clinician criticism of MOC is being framed less as irritation with requirements and more as a legal and structural challenge to who controls continuous professional development.
• The strongest public voices this week were hematology/oncology-led, but the argument is aimed at hospitals, states, insurers, and the broader profession.
• CME providers should pressure-test which offerings would still matter if certification-linked credit stopped being the main reason clinicians showed up.

Clinicians this week put sharper legal language around MOC, calling it a monopoly and an antitrust problem rather than just a burdensome credentialing process. The loudest public signal came from hematology/oncology voices, but the provider implication is broader: CME teams may need to prove value in a world where required credit is a weaker shield.

The fight is moving from compliance to control

In a publicly shared clip, clinicians described efforts to go to states and pursue legislation to end maintenance of certification, with one saying, “Because we believe it violates antitrust law.” The argument in the shared video was not simply that MOC is inconvenient. It was that a credentialing body has too much control over continuous professional development, has marketed MOC as a quality metric, and has not proved that the requirement improves patient care quality or safety.

That matters because CME has often benefited from the same compliance economy clinicians are now attacking. If the policy fight continues, the question for providers is not whether an activity carries enough credit. It is whether the learning experience would be trusted by clinicians, hospitals, or states as a legitimate substitute for certification-driven participation.

This extends an earlier brief on certification policy and meaningful learning: the tension has moved from choosing better CME within certification rules to challenging the rules themselves. In parallel, provider-owned CME discussion this week emphasized the demand for formats that are personalized, just-in-time, measurable, and able to adapt faster than older frameworks; as one episode put it, “Learners demand personalized, just-in-time education, healthcare systems expect measurable outcomes, and technology is evolving faster than our traditional frameworks can adapt.” That conversation is not independent clinician corroboration, but it does name the standard CME will be judged against if MOC loses some of its default force.

The concrete implication: audit any activity whose main value proposition is certification-linked credit. If the credit disappeared, would the activity still solve a real practice problem, produce credible evidence of learning or performance change, and be easy enough to use in the clinician’s actual workflow?

What CME Providers Should Reconsider

• Separate portfolio value into two columns: activities clinicians use because they need credit, and activities they would still use because the learning is timely, trusted, and useful.
• Identify one or two programs that could be described to a hospital or state medical board as flexible CPD with clear objectives, front-end assessment, and outcomes evidence.
• Review MOC-dependent messaging. If the first promise is credit, rewrite the offer around the clinical or operational problem the activity helps clinicians handle.

The open question

The AI item this week was not strong enough for a main section, but it points to the same accountability test. A medical education panel described a review of LLMs by saying, “The aim of the paper was to review and analyze the literature on large language models, focusing on its impact in medical education,” and then emphasized hallucinations, over-reliance, integrity, privacy, and bias concerns in the discussion. That is a reminder for CME teams: the future of professional learning will not be won by replacing one required structure with another thin claim. Whether the pressure comes from MOC, AI, or outcomes expectations, the durable question is the same: can the provider show why this learning deserves clinician trust when participation is not guaranteed by obligation?